Benzinga | Oct 22, 2021 06:55AM EDT

Roper Technologies Will Divest CIVCO Radiotherapy For $120M In Cash

Roper Technologies, Inc. (NYSE:ROP), a leading diversified technology company, today announced that it has reached a definitive agreement to sell its CIVCO Radiotherapy business to an affiliate of Blue Wolf Capital Partners LLC, a private equity firm, in an all-cash transaction valued at $120 million. Roper will retain its CIVCO Medical Solutions business, which will continue to operate independently.

Roper retained William Blair as a financial advisor in connection with this transaction. Roper expects the transaction to close in the fourth quarter, subject to customary closing conditions.